Tags

Type your tag names separated by a space and hit enter

Intravenous immunoglobulins for the management of Stevens-Johnson syndrome with minimal skin manifestations.
Eur J Pediatr. 2007 Jun; 166(6):585-8.EJ

Abstract

Here we describe the successful use of intravenous immunoglobulin (IVIG) in the management of mycoplasma-induced, atypical Stevens-Johnson syndrome (SJS) with minimal skin manifestations. The patient was successfully managed with high-dose IVIG 0.5 g/kg for 4 consecutive days. No complications were noted. IVIG may be useful in the management of mycoplasma-induced SJS.

Authors+Show Affiliations

Jenny Lind Children's Department, Norfolk and Norwich University Hospital, Colney Lane, Norwich, NR4 7UY, UK. czipitis@hotmail.comNo affiliation info available

Pub Type(s)

Case Reports
Journal Article

Language

eng

PubMed ID

17008995

Citation

Zipitis, Christos S., and Nandu Thalange. "Intravenous Immunoglobulins for the Management of Stevens-Johnson Syndrome With Minimal Skin Manifestations." European Journal of Pediatrics, vol. 166, no. 6, 2007, pp. 585-8.
Zipitis CS, Thalange N. Intravenous immunoglobulins for the management of Stevens-Johnson syndrome with minimal skin manifestations. Eur J Pediatr. 2007;166(6):585-8.
Zipitis, C. S., & Thalange, N. (2007). Intravenous immunoglobulins for the management of Stevens-Johnson syndrome with minimal skin manifestations. European Journal of Pediatrics, 166(6), 585-8.
Zipitis CS, Thalange N. Intravenous Immunoglobulins for the Management of Stevens-Johnson Syndrome With Minimal Skin Manifestations. Eur J Pediatr. 2007;166(6):585-8. PubMed PMID: 17008995.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Intravenous immunoglobulins for the management of Stevens-Johnson syndrome with minimal skin manifestations. AU - Zipitis,Christos S, AU - Thalange,Nandu, Y1 - 2006/09/29/ PY - 2006/05/24/received PY - 2006/08/17/accepted PY - 2006/9/30/pubmed PY - 2007/9/21/medline PY - 2006/9/30/entrez SP - 585 EP - 8 JF - European journal of pediatrics JO - Eur J Pediatr VL - 166 IS - 6 N2 - Here we describe the successful use of intravenous immunoglobulin (IVIG) in the management of mycoplasma-induced, atypical Stevens-Johnson syndrome (SJS) with minimal skin manifestations. The patient was successfully managed with high-dose IVIG 0.5 g/kg for 4 consecutive days. No complications were noted. IVIG may be useful in the management of mycoplasma-induced SJS. SN - 0340-6199 UR - https://www.unboundmedicine.com/medline/citation/17008995/Intravenous_immunoglobulins_for_the_management_of_Stevens_Johnson_syndrome_with_minimal_skin_manifestations_ L2 - https://dx.doi.org/10.1007/s00431-006-0287-9 DB - PRIME DP - Unbound Medicine ER -